Search for: "In re R. F."
Results 5861 - 5880
of 10,010
Sorted by Relevance
|
Sort by Date
23 Jul 2018, 7:44 am
R. [read post]
21 Jan 2007, 4:16 pm
In re Sealed Case, 332 U.S. [read post]
1 Jul 2007, 2:31 pm
(DEUTSCHE VEREINIGUNG FÃœR GEWERBLICHEN RECHTSSCHUTZ UND URHEBERRECHT).In preparation, I have been thinking about what copyrights would be of interest to German students and attorneys. [read post]
1 Sep 2011, 6:15 am
If you're not sure whether an item should be refrigerated to maintain quality, ask your grocer. [read post]
12 Dec 2011, 3:03 pm
Rendon, 354 F.3d 1320, 1325 (11th Cir. 2003). [read post]
30 Apr 2015, 8:55 am
Contact the Law Firm of Sean F. [read post]
28 Jan 2011, 7:23 am
Agri-Systems, Inc., 542 F. [read post]
18 Aug 2015, 8:02 am
The Law Offices of Sean F. [read post]
1 Sep 2011, 6:15 am
If you're not sure whether an item should be refrigerated to maintain quality, ask your grocer. [read post]
22 Mar 2011, 9:49 am
" In re Bigio, 381 F.3d 1320, 1325 (Fed. [read post]
23 Apr 2008, 7:35 pm
Menino of Boston and House Speaker Salvatore F. [read post]
28 Jun 2010, 2:11 pm
., State Street, 149 F. 3d, at 1373; AT&T Corp., 172 F. 3d, at 1357. [read post]
27 Jan 2022, 2:54 pm
” R. [read post]
15 Sep 2013, 4:00 am
Intitulé : R. c. [read post]
3 Dec 2018, 8:46 pm
(Cole.pdf) John F. [read post]
11 Dec 2007, 10:44 am
Erstere hat den entsprechenden Beweis ohnehin zu führen, der Streitgenosse sich ohnehin dagegen zu verteidigen. [read post]
1 Dec 2017, 1:10 am
The Global Magnitsky Human Rights Accountability Act (Subtitle F in P.L. 114-328) and the Frank R. [read post]
28 Mar 2014, 5:33 pm
See In re Hogan, 559 F.2d 595, 606 (CCPA 1977) (noting that requiring such specific disclosures would 'impose an impossible burden on inventors'). . . . [read post]
25 Nov 2020, 1:17 am
, https://www.ip-watch.org/2016/11/14/wto-paragraph-6-system-affordable-medicines-time-change. [5] F. [read post]
5 Jan 2022, 7:16 am
The case, In Re Valsartan, Losartan, and Irbesartan Products Liability Litigation (US DC NJ) MDL No. 2875 (RBK)is a products liability case that concerns the sale in the U.S. of generic, prescription Valsartan pharmaceuticals, found by the Food and Drug Administration [“FDA”] to contain cancer‐causing contaminants. [read post]